J 2024

The impact of obesity, age, and gender on plasmatic levels of selected glycoprotein biomarkers and miRNA-499 in OSA patients

KOSTLIVY, Tomas, Martin PESTA, Jindra WINDRICHOVA, Petr SKOPEK, Pavel KLAIL et. al.

Základní údaje

Originální název

The impact of obesity, age, and gender on plasmatic levels of selected glycoprotein biomarkers and miRNA-499 in OSA patients

Autoři

KOSTLIVY, Tomas (203 Česká republika), Martin PESTA (203 Česká republika), Jindra WINDRICHOVA (203 Česká republika), Petr SKOPEK (203 Česká republika), Pavel KLAIL (203 Česká republika), Alena SKALOVA (203 Česká republika), Břetislav GÁL (203 Česká republika, domácí), Radek KUCERA (203 Česká republika), Krista PLICKOVA (203 Česká republika), Vaclav SIMANEK (203 Česká republika) a David SLOUKA (203 Česká republika)

Vydání

Journal of applied biomedicine, České Budějovice, Faculty of Health and Social Care, University of South Bohemia, 2024, 1214-021X

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30206 Otorhinolaryngology

Stát vydavatele

Česká republika

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 1.300 v roce 2022

Organizační jednotka

Lékařská fakulta

UT WoS

001246575700001

Klíčová slova anglicky

Biomarkers; Diagnostic process; microRNA; Obstructive sleep apnoea

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 5. 11. 2024 14:15, Mgr. Tereza Miškechová

Anotace

V originále

Background: The current obstructive sleep apnea (OSA) diagnostic uses polysomnography or limited polygraphy and requires specialized personnel and technical equipment. Glycoprotein biomarkers and microRNAs are being explored as a possible new method for screening. We aimed to evaluate whether certain biomarkers and microRNA, previously identified as related to OSA, could be influenced by factors such as gender, age, and obesity level in patients with OSA. Methods: In this retrospective analytical study, patients with moderate to severe OSA (n = 130) were compared with the control group. Serum levels of selected biomarkers and microRNA were taken from both groups. The group of OSA patients was then stratified by gender, obesity level, and age to see the possible influence of those variables on biomarker levels. Results: Levels of all studied biomarkers - C-reactive protein (CRP), high-sensitivity troponin I (hsTnI), pentraxin-3 (PTX-3), and microRNA-499 were significantly higher in patients with OSA compared to the control group. In the OSA group only hsTnI showed a statistically significant relationship with gender. Levels of CRP and hsTnI showed a significant dependence on the level of obesity. Dependency on age was proven for hsTnI. CRP, PTX-3, and microRNA-499 did not have any statistically significant relationship with age. Conclusion: We found that serum levels of pentraxin-3 and microRNA-499 in patients with moderate to severe obstructive sleep apnoea are independent of gender, obesity, and age. CRP was affected by the level of obesity and hsTnI was influenced by all 3 variables. We consider these findings important for further research of OSA biomarkers.

Návaznosti

90125, velká výzkumná infrastruktura
Název: BBMRI-CZ III